期刊文献+

端粒酶逆转录酶小干扰RNA对结肠癌SW480细胞体外抑制作用的观察 被引量:2

Anti-cancer effect of siRNA targeting human telomerase reverse transcriptase in SW480 cells
原文传递
导出
摘要 目的:探讨RNA干扰(RNAi)对结肠癌SW480细胞人端粒酶逆转录酶(hTERT)基因的抑制效应。方法:化学合成靶向于hTERT基因的4个小分子干扰RNA(siRNA)序列,用阳离子脂质体为载体转染SW480细胞,分为siRNA1~4、siRNA阴性对照和空白对照6组。通过RT-PCR和蛋白质印迹法分别检测结肠癌细胞转染后细胞hTERT mRNA和蛋白水平,并用MTS法检测细胞生长增殖。结果:siRNA1~4组hTERT mRNA相对表达量分别为0.54±0.18、0.56±0.19、0.46±0.10和0.84±0.18,端粒酶相对活性分别为0.57±0.18、0.56±0.19、0.09±0.08和0.70±0.19,siRNA1~4组hTERT蛋白相对表达量分别为0.41±0.18、0.45±0.17、0.08±0.07和0.82±0.16,其中siR-NA1~3组的hTERT mRNA表达量、端粒酶活性和蛋白表达量与空白对照组的差异有统计学意义,P<0.05。SW480细胞在转染后48h时的细胞增长平均抑制率分别为42.14%、39.12%、48.05%和35.85%。提示不同siRNA序列对SW480的转染效率不同,其中siRNA3组能显著下调hTERT mRNA和蛋白的表达水平,并能抑制端粒酶活性和促进SW480细胞凋亡,与空白对照组比较均差异有统计学意义,P<0.01。结论:靶向hTERT的RNAi能明显抑制SW480的增殖,hTERT可作为结肠癌基因治疗的靶点。 OBJECTIVE:To explore the inhibitory effect of RNA interference (RNAi) targeting human telomerase reverse transcriptase (hTERT) gene of colon carcinoma SW480 cells. METHODS: Four small interfering RNAs (siRNAs) targeting hTERT gene were synthesized by chemistry, and siRNAs were transfected into SW480 cells by cationic liposome. And SW480 cells were divided into six groups: blank group (untransfected SW480 cells group), siRNA-NC group(negative control group), siRNA 1-- 4 group(RNA interference group). The hTERT mRNA, hTERT protein and telomerase activity were detected by RT PCR,Western blot and TRAP process, respectively. The proliferation of the SW480 cell was analyzed by MTS kits. RESULTS: The hTERT mRNA relative expression of siRNA 1--4 groups after transfection were as follow: 0.54±0.18,0.56±0.19,0.46±0.10,0.84± 0.18. The telomerase relative activity of siRNA 1- 4 groups were 0. 57±0.18,0. 56±0. 19,0.09±0. 08,0.70±0.19, respectively. The relative expression level of hTERT protein of siRNA 1- 4 groups were 0.41±0.18,0.45±0.17,0.08±0. 07,0.82±0.16, respectively. SW480 cells average inhibition rate were 42. 14%, 39.12% ,48.05% ,35.85% ,respectively. In contrast to the blank groups, the relative expression level of the hTERT mRNA and pro- tein and telomerase activity of siRNA-3 group was declined (P〈 0. 05),in addition,the difference of them in siRNA 3 group vs the blank were significant (P〈0.01). CONCLUSIONS: RNAi can in- hibit the proliferation of the cancer cells. The hTERT may be a target point of gene therapy for Colon carcinoma.
出处 《中华肿瘤防治杂志》 CAS 2011年第21期1676-1680,共5页 Chinese Journal of Cancer Prevention and Treatment
基金 上海市卫生局青年项目(2009Y127) 上海市普陀区科委重点项目(PTKW10-B01)
关键词 端粒 末端转录酶 结肠肿瘤 细胞系 肿瘤 RNA干扰 RNA 小分子干扰 telomerase colonic neoplasms cell line, tumor RNA interference RNA, small interfering
  • 相关文献

参考文献20

二级参考文献91

共引文献42

同被引文献36

  • 1卫立辛,吴孟超.端粒酶:肿瘤治疗研究的新希望[J].中国肿瘤生物治疗杂志,2006,13(5):325-328. 被引量:20
  • 2Fraser A. RNA interference human genes hit the big screen [ J ]. Nature, 2004, 428(6981 ) : 375-378.
  • 3Jemal A, Siegel R, Ward E, et al. Cancer statisties [ J]. CA Cancer J Clin, 2009, 59(4) : 225-249.
  • 4Ferlay J, Autier P, Boniol M, et al. Estimates of the cancer inei- denee and mortality in Europe in 2006 [ J ]. Ann Oneol, 2007, 18(3) : 581-592.
  • 5Willers H, McCarthy EE, Alberti W, et al. Loss of wild-type 1'53 function is responsible for upregulated homologous recombination in immortal rodent fibroblasts [J]. Int J Radiat Biol, 2007, 76(8) : 1055-1062.
  • 6Opitz OG, Suliman Y, Hahn WC, et al. Cyclin Dloverexpression and p53 inactivation immortalize primary oral keratinacytes by a te- lomerase-independent mechanism [J]. J Clin Invest, 2001, 108 (5) : 725-732.
  • 7Luzar B, Poljak M, Matin lJ, et al. Quantitative measurement of telomerase catalytic subunit (hTER mRNA in laryngeal squa- mous cell carcinomas [ J ]. Anticaner Res, 2001, 21 ( 6A ) :40114015.
  • 8Lehner R, Enomoto T, McGregor JA, et al. Quantitative analysis of telomerase hTERT mRNA and telomerase activity in endometri- oid adenocarcinoma and in normal endometrium [ J ]. Gynecol Oncol, 2002, 84( 1 ) : 120-125.
  • 9Hara H, Yamashita K, Shinada J, et al. Clinicopathologic signifi- cance of telomerase activity and hTERT mRNA expression in non- small cell lung canaer [J]. Lung Cancer, 2001, 34(2): 219- 226.
  • 10de Fougerelles A, Vomlocher HP, Maraganore J, et al. Interfered- with disease: A progress report on siRNA-based therapeutics [ J]. Nat Rev Drug Discovery, 2007, 6(6) : 4432-4453.

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部